BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART;VALUE=DATE:20250101
TZNAME:UTC
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:14:00 - 15:30 UK Time\n\nIn this webinar\, the EU regulatory an
 d Industry members of the ICH E9(R1) working group will present the new dr
 aft addendum for ICH E9 on estimands and sensitivity analysis.&nbsp\; The 
 addendum introduces a new framework for designing and analysing clinical t
 rials aligned to the trial objectives.&nbsp\;&nbsp\; \n\nClick here&nbsp\;
 to view the flyer.\n\nRob Hemmings (MHRA) will present the motivation behi
 nd the new draft addendum\, define estimands and sensitivity analysis\, an
 d explain different strategies that can be used in constructing an estiman
 d.\n\nFrank Bretz (Novartis) will present case studies to illustrate how t
 he new framework can be implemented in designing clinical trials and defin
 ing the appropriate analysis methods.\n\nA Q&amp\;A session will be chaire
 d by Frank P&eacute\;tavy (EMA) and Chrissie Fletcher (Amgen).\nThis webin
 ar is free to attend.&nbsp\;\n\nClick here&nbsp\;to view the presentation 
 slides \nTo access the recording\, please visit the Video-on-Demand Librar
 y.
DTEND:20171030T153000Z
DTSTAMP:20260912T163217Z
DTSTART:20171030T140000Z
LOCATION:
SEQUENCE:0
SUMMARY:EFPSI/EFPIA Webinar: New draft ICH E9 addendum on Estimands and Sen
 sitivity Analysis
UID:RFCALITEM639248275376339781
X-ALT-DESC;FMTTYPE=text/html:<p><strong>14:00 - 15:30 UK Time</strong><br /
 >\n<br />\nIn this webinar\, the EU regulatory and Industry members of the
  ICH E9(R1) working group will present the new draft addendum for ICH E9 o
 n estimands and sensitivity analysis.&nbsp\; The addendum introduces a new
  framework for designing and analysing clinical trials aligned to the tria
 l objectives.&nbsp\;&nbsp\; <br />\n<br />\n<a href="https://www.psiweb.or
 g/docs/default-source/default-document-library/webinar-advert-oct-2017-fin
 al-v.pdf?sfvrsn=bcddcdb_0&sf_site_temp=true&sf_site=00000000-0000-0000-000
 0-000000000000" title="Click here">Click here</a>&nbsp\;to view the flyer.
 <br />\n<br />\n<strong>Rob Hemmings (MHRA)</strong> will present the moti
 vation behind the new draft addendum\, define estimands and sensitivity an
 alysis\, and explain different strategies that can be used in constructing
  an estimand.<br />\n<br />\n<strong>Frank Bretz (Novartis) </strong>will 
 present case studies to illustrate how the new framework can be implemente
 d in designing clinical trials and defining the appropriate analysis metho
 ds.<br />\n<br />\nA Q&amp\;A session will be chaired by <strong>Frank P&e
 acute\;tavy (EMA)</strong> and <strong>Chrissie Fletcher (Amgen)</strong>.
 </p>\n<p>This webinar is free to attend.&nbsp\;<br />\n<br />\n<a href="ht
 tps://www.psiweb.org/docs/default-source/default-document-library/estimand
 -webinar-30-oct-2017.pdf?sfvrsn=36fbdcdb_0&sf_site_temp=true&sf_site=00000
 000-0000-0000-0000-000000000000" title="Estimand webinar 30 Oct 2017">Clic
 k here</a>&nbsp\;to view the presentation slides </p>\n<strong>To access t
 he recording\, please visit the <a href="https://psiweb.org/vod">Video-on-
 Demand Library</a>.</strong>
END:VEVENT
END:VCALENDAR